Daniel Paull, PhD

Daniel Paull, PhD, is VP of Discovery and Platform Development at the JAX-NYSCF Collaborative. He earned his PhD from University College London and, during his postdoc with Dr. Dieter Egli, helped develop Mitochondrial Replacement Therapy, a technique now in clinical trials. At NYSCF, he created the Global Stem Cell Array®, an automated platform for generating, editing, and analyzing human cells at scale. With expertise spanning stem cell biology, genetics, and engineering, he has led the development of software and hardware infrastructure supporting this cutting-edge technology and led programs studying diseases from diabetes to Alzheimer’s and PTSD. His team has used AI and deep learning to detect subtle cellular signatures of Parkinson’s disease and is now expanding these tools to screen and study drug and toxicant effects across human cell types, including neurons, astrocytes, and microglia.